Alunbrig
NDC 63020-180, brigatinib, tablet, film coated, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 63020-180
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208772
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63020-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIGATINIB180 mg/1
Pharmacologic classes
Cytochrome P450 3A Inducers [MoA]; Kinase Inhibitor [EPC]; Tyrosine Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63020-180-30 | 63020018030 | 30 TABLET, FILM COATED in 1 BOTTLE (63020-180-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0fe9ff20-d402-41f3-bc1e-7002ea7007db
Use it
Look up 63020-180 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63020-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63020-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.